Repurposed drug shows promise for treating COVID-19 inflammation
Yale clinicians report promising results after treating COVID-19 with the drug tocilizumab, which is known to reduce inflammation in chemotherapy patients.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Actemra | Chemotherapy | COVID-19 | Health | Science | Universities & Medical Training | Yale